Susquehanna Analyst Starts IBM at Neutral, $303 Target

Susquehanna analyst James Friedman initiated coverage of IBM (NYSE: IBM) with a Neutral rating and a $303 price target, according to a report from Barron's.

Rating Change

This is Friedman's first coverage of IBM, so there is no prior rating to compare. A Neutral rating suggests the analyst expects the stock to perform in line with the broader market.

Analyst's Rationale

Friedman sees IBM as a strategic play in quantum computing, a nascent but high-growth sector. However, he believes the stock is currently trading at a fair valuation, limiting upside potential. The $303 price target represents a modest premium over the current trading price.

Context

No other analysts have issued new commentary on IBM alongside this coverage. IBM shares are trading around $290, up about 15% year-to-date. The stock remains a popular choice for investors seeking exposure to AI and quantum computing.

What We Conclude

Friedman's Neutral rating suggests IBM may be a good long-term hold for quantum computing enthusiasts, but it does not offer a compelling buying opportunity at current valuation levels.